Navegação Technical documents and research evidence on COVID-19 por título
Itens para a visualização no momento 1584-1603 of 1749
-
The University of California Zika Virus Project
(2016-06)7 Feb 2016 – In the Spring of 2016, we infected 2 nonpregnant females with Brazilian ZIKV and monitored them for 2 weeks to look at viral kinetics and distribution. The data and methods were published in February 2017. In ... -
Unrevealing Sequence and Structural Features of Novel Coronavirus Using In Silico Approaches: The Main Protease as Molecular Target
(2020-03-17)Direct-acting antivirals are effective tools to control viral infections. SARS-CoV-2 is a coronavirus associated with the epidemiological outbreak in late 2019. Previous reports showed that HIV-1 protease inhibitors could ... -
An update on CT chest findings in coronavirus disease-19 (COVID-19)
(2020-03-20)A recent outbreak of Coronavirus 2019 (SARS-CoV-2) has shattered the world and has been declared a pandemic by World Health Organization (WHO) on 11th March 2020 (Fig. 1). When clinicians worldwide are actively suspecting ... -
Update on Zika virus transmission in the Pacific islands, 2007 to February 2016 and failure of acute flaccid paralysis surveillance to signal Zika emergence in this setting
(2016-06)Objective: To describe the distribution and magnitude of Zika virus (ZIKV) infections reported in the Pacific islands from 2007 to February 2016; and explore the utility of routine acute flaccid paralysis (AFP) surveillance ... -
Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-July 7, 2016
(2016-08)Zika virus is a flavivirus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, and infection can be asymptomatic or result in an acute febrile illness with rash (1). Zika virus infection during pregnancy ... -
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
(2020-03-25)The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world. Reports from China showed that about 20% of patients developed severe disease, resulting in a fatality of 4%. In the ... -
Use of chest imaging in COVID-19. A rapid advice guide, 11 June 2020
(2020-06-11)This rapid advice guide examines the evidence and makes recommendations for the use of chest imaging in acute care of adult patients with suspected, probable or confirmed COVID-19. Imaging modalities considered are ... -
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review
(2020-12-23)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19), a severe illness leading to pneumonia, multiorgan failure, and death. With this study, we performed ... -
The use of google trends to investigate the loss of smell related searches during COVID‐19 outbreak
(2020-04-11)[Abstract]. Background: Initial reports describing COVID‐19 were dominated by the presence of cough, breathlessness, and fever, anecdotal reports suggested anosmia may also be a manifestation. We sought to use Google Trends ... -
Use of in situ simulation to evaluate the operational readiness of a high‐consequence infectious disease intensive care unit
(2020-03-27)On 30 January 2020, the World Health Organization (WHO) declared that the outbreak of a coronavirus disease‐2019 (COVID‐19) was a public health emergency of international concern. The WHO guidance states that patients with ... -
Use of medical scribes in health care settings
(2020-05-15)What is this? The COVID-19 pandemic is placing a strain on healthcare services. The involvement of medical scribes to enter information into electronic health records (EHRs) during healthcare encounters may improve ... -
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. Scientific Brief, 19 April 2020
(2020-04-18)Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs, and have a wide range of uses. NSAIDs include nonselective cyclooxygenase (COX) inhibitors (such as ibuprofen, aspirin ... -
Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19
(2020-04-02)[Abstract]. Background: Given the extensive time needed to conduct a nationally representative household survey and the commonly low response rate of phone surveys, rapid online surveys may be a promising method to assess ... -
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
(2020-06-27)Background and Aims: To investigate the association between use of angiotensin-converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of hypertensive COVID-19 patients, a systematic review and ... -
The use of tunnels and other technologies for disinfection of humans using chemical aspersion or UV-C Light
(2020-05-05)The use of tunnels or other physical structures (booths, cabinets, gates) with disinfection aspersion, spray devices or UV-C radiation are not recommended for use on humans. -
Utilising additional sources of information on microcephaly
(2016-06)When the Zika virus outbreak was declared a Public Health Emergency of International Concern on Feb 1, 2016, the WHO International Health Regulations Emergency Committee made several recommendations. One of them was for ... -
Utility of extracorporeal membrane oxygenation in COVID-19
(2020-05-05)Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. ... -
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance
(2020-04-25)Since emergence of SARS-CoV-2 in late 2019, there has been a critical need to understand prevalence, transmission patterns, to calculate the burden of disease and case fatality rates. Molecular diagnostics, the gold standard ...